The TriGrid® Delivery System has been used for delivery of nucleic acid candidates encoding antigens, proteins and monoclonal antibodies in clinical stage programs in the U.S., E.U., U.K., Korea, and East Africa.

Clinical testing using the TriGrid for delivery has shown:

Improved cellular response versus conventional injection demonstrated in randomized, placebo controlled trials

Vasan S, et al., PLoS One. 2011;6(5):e19252

TriGrid Clinical Programs (Therapeutic)

 TriGrid Clinical Programs (Prophylactic)